Hageman Factor, Platelets and Polyphosphates: Early History and Recent Connection

Overview

Journal J Thromb Haemost

Publisher Elsevier

Specialty Hematology

Date 2010 May 12

PMID 20456750

Citations 19

Authors

J Caen

Q Wu

Affiliations

Soon will be listed here.

Abstract

Platelet activation and blood coagulation are essential for hemostasis and contribute to a variety of other biological processes such as inflammation, complement activation and tissue repair. Factor (F)XII, originally called Hageman factor, plays an important role in the kallikrein-kinin system by activating prekallikrein. In the 1960s, a platelet activity that promoted FXII activation was identified but its biochemical nature remained unknown. Inorganic polyphosphates (poly P) are polymers that consist of many phosphate residues linked by phosphoanhydride bonds. These polymers exist in all living organisms. In bacteria, poly P is important for growth and survival. Recently, poly P has been identified in human platelet dense granules. Studied have shown that upon platelet activation and secretion, poly P activates FXII, indicating that it is most likely the elusive platelet FXII activator. Poly P also regulates coagulation and fibrinolysis. In this review, we focus on early studies of FXII and the identification of platelet FXII activation activity, and discuss recent findings of poly P in FXII activation and coagulation.

Citing Articles

Cardiopulmonary bypass in a pediatric patient with factor XII deficiency.

Fenske J, Tinius Juliani J, Herrington C J Extra Corpor Technol. 2024; 56(3):125-127.

PMID: 39303135 PMC: 11415032. DOI: 10.1051/ject/2024021.

An Update on Polyphosphate In Vivo Activities.

Schoeppe R, Waldmann M, Jessen H, Renne T Biomolecules. 2024; 14(8).

PMID: 39199325 PMC: 11352482. DOI: 10.3390/biom14080937.

Prolonged activated partial thromboplastin time secondary to factor XII deficiency in two surgical patients.

Moiz B, Sadiq M, Javed M, Jafry B, Anees M Oxf Med Case Reports. 2021; 2021(3):omaa146.

PMID: 33732475 PMC: 7947263. DOI: 10.1093/omcr/omaa146.

Polyphosphate, Zn and high molecular weight kininogen modulate individual reactions of the contact pathway of blood clotting.

Wang Y, Ivanov I, Smith S, Gailani D, Morrissey J J Thromb Haemost. 2019; 17(12):2131-2140.

PMID: 31420909 PMC: 6893101. DOI: 10.1111/jth.14612.

Schistosomes can hydrolyze proinflammatory and prothrombotic polyphosphate (polyP) via tegumental alkaline phosphatase, SmAP.

Elzoheiry M, Dadara A, Nation C, El-Beshbishi S, Skelly P Mol Biochem Parasitol. 2019; 232:111190.

PMID: 31154018 PMC: 6717558. DOI: 10.1016/j.molbiopara.2019.111190.

References

King S, McNamee R, Houng A, Patel R, Brands M, Reed G . Platelet dense-granule secretion plays a critical role in thrombosis and subsequent vascular remodeling in atherosclerotic mice. Circulation. 2009; 120(9):785-91. PMC: 2761818. DOI: 10.1161/CIRCULATIONAHA.108.845461. View

Mackman N . Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004; 24(6):1015-22. DOI: 10.1161/01.ATV.0000130465.23430.74. View

Smith S, Morrissey J . Polyphosphate enhances fibrin clot structure. Blood. 2008; 112(7):2810-6. PMC: 2556616. DOI: 10.1182/blood-2008-03-145755. View

Muller F, Mutch N, Schenk W, Smith S, Esterl L, Spronk H . Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell. 2009; 139(6):1143-56. PMC: 2796262. DOI: 10.1016/j.cell.2009.11.001. View

Roberts H . Oscar Ratnoff: his contributions to the golden era of coagulation research. Br J Haematol. 2003; 122(2):180-92. DOI: 10.1046/j.1365-2141.2003.04459.x. View

Wu Q, Picard V, Aiach M, Sadler J . Activation-induced exposure of the thrombin anion-binding exosite. Interactions of recombinant mutant prothrombins with thrombomodulin and a thrombin exosite-specific antibody. J Biol Chem. 1994; 269(5):3725-30. View

Ratnoff O . The George M. Kober lecture. The legacy of John Hageman: new dividends. Trans Assoc Am Physicians. 1985; 98:cli-clxi. View

MAJERUS P, Miletich J . Relationships between platelets and coagulation factors in hemostasis. Annu Rev Med. 1978; 29:41-9. DOI: 10.1146/annurev.me.29.020178.000353. View

Sainz I, Pixley R, Colman R . Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology. Thromb Haemost. 2007; 98(1):77-83. View

10.

Bode W . The structure of thrombin: a janus-headed proteinase. Semin Thromb Hemost. 2006; 32 Suppl 1:16-31. DOI: 10.1055/s-2006-939551. View

11.

Furie B, Furie B . Thrombus formation in vivo. J Clin Invest. 2005; 115(12):3355-62. PMC: 1297262. DOI: 10.1172/JCI26987. View

12.

Caen J, Bernard J . [Hageman factor deficiency]. Rev Hematol. 1958; 13(2):154-62. View

13.

Ruiz F, Lea C, Oldfield E, Docampo R . Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem. 2004; 279(43):44250-7. DOI: 10.1074/jbc.M406261200. View

14.

Muta T, Iwanaga S . The role of hemolymph coagulation in innate immunity. Curr Opin Immunol. 1996; 8(1):41-7. DOI: 10.1016/s0952-7915(96)80103-8. View

15.

Ratnoff O . A quarter century with Mr. Hageman. Thromb Haemost. 1980; 43(2):95-8. View

16.

Wu Q, Tsiang M, Sadler J . Localization of the single-stranded DNA binding site in the thrombin anion-binding exosite. J Biol Chem. 1992; 267(34):24408-12. View

17.

Spaet T, CINTRON J . STUDIES ON PLATELET FACTOR-3 AVAILABILITY. Br J Haematol. 1965; 11:269-75. DOI: 10.1111/j.1365-2141.1965.tb06587.x. View

18.

Davie E . A brief historical review of the waterfall/cascade of blood coagulation. J Biol Chem. 2003; 278(51):50819-32. DOI: 10.1074/jbc.X300009200. View

19.

Morrissey J . Tissue factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol. 2004; 79(2):103-8. DOI: 10.1532/ijh97.03167. View

20.

Broze Jr G . Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med. 1995; 46:103-12. DOI: 10.1146/annurev.med.46.1.103. View